Open Access Journal of Clinical Trials
Scope & Guideline
Your Gateway to Cutting-Edge Clinical Research.
Introduction
Aims and Scopes
- Clinical Trial Methodologies:
The journal emphasizes the development and evaluation of various clinical trial designs, including randomized controlled trials, pilot studies, and pragmatic trials, ensuring robust methodological standards. - Patient-Centric Research:
Research focused on participant compliance, satisfaction, and engagement in clinical trials highlights the importance of patient perspectives in the design and implementation of health interventions. - Interventions for Vulnerable Populations:
A consistent focus on clinical trials targeting specific age groups or vulnerable populations, such as older adults, individuals with chronic conditions, and patients with mental health issues, showcases the journal's commitment to addressing health disparities. - Translational Research:
The journal publishes findings that bridge the gap between laboratory research and clinical practice, promoting the application of scientific discoveries in real-world settings. - Holistic and Multidomain Interventions:
Research on multifaceted interventions, particularly for chronic conditions and mental health, emphasizes the complexity of health challenges and the need for comprehensive treatment approaches.
Trending and Emerging
- COVID-19 Related Research:
The journal has seen a significant increase in studies related to COVID-19, including vaccine efficacy and treatment protocols, reflecting the ongoing global health crisis and the need for timely research. - Mental Health Interventions:
There is a growing emphasis on mental health, particularly interventions designed for specific populations, such as older adults with HIV, indicating a recognition of the increasing importance of mental well-being in overall health outcomes. - Home-Based Healthcare Interventions:
Research focused on home-based interventions, such as home blood pressure monitoring, is trending, showcasing a shift towards patient-centered care that empowers individuals to manage their health in familiar settings. - Social Support Mechanisms:
Emerging themes around social support interventions for chronic disease management, like diabetes, highlight the importance of community and social networks in improving health outcomes.
Declining or Waning
- Traditional Medicine Trials:
Although the journal has recently published work on traditional Chinese medicine, the broader focus on alternative and complementary therapies appears to be declining, possibly due to a growing emphasis on evidence-based practices. - Single-Dose Trials:
The publication of single-dose trials has become less frequent, indicating a possible shift towards more comprehensive intervention studies that assess longer-term effects and multi-dose strategies. - Niche Pharmaceutical Interventions:
Research on specific pharmaceutical alternatives, such as the Gabapentinoid for cocaine consumption problems, has decreased, suggesting a trend towards broader health interventions rather than niche pharmaceutical solutions.
Similar Journals
Traditional Medicine Research
Unlocking the Secrets of Herbal TherapiesTraditional Medicine Research is a pioneering journal dedicated to advancing the field of traditional medicine through impactful research and scholarly discourse. Published by TMR Publishing Group, this Open Access journal has been committed to enhancing the accessibility of invaluable research since 2016. With its ISSN 2413-3973, it provides a platform for researchers, professionals, and students to explore and disseminate knowledge pertaining to various aspects of traditional medicinal practices, herbal therapies, and integrative healthcare solutions. Positioned to bridge the gap between ancient wisdom and modern scientific inquiry, Traditional Medicine Research plays a crucial role in fostering a deeper understanding of therapeutic traditions and their applications in contemporary health contexts. Scholars and practitioners are encouraged to engage with the latest findings, share innovative methodologies, and contribute to a vibrant community focused on the evolution and validation of traditional medicine.
International Journal of Biostatistics
Transforming Data into Health Solutions.The International Journal of Biostatistics, published by Walter de Gruyter GmbH, stands as a critical platform for advancements in the fields of biostatistics and applied statistics in medicine. With an ISSN of 2194-573X and an E-ISSN of 1557-4679, this journal has gained recognition for its rigorous peer-reviewed articles that bridge theoretical statistics and its practical applications in health sciences, maintaining a commendable Q2 quartile ranking in both Medicine and Statistics categories as of 2023. Hosted in Germany, the journal's pivotal role lies in disseminating innovative research findings that guide public health decisions and inform healthcare policy, thus appealing to a diverse readership including researchers, healthcare professionals, and students. Although the journal operates under a subscription model, it remains committed to providing valuable insights into the statistical methods that support evidence-based medicine and improve health outcomes globally. For those engaged in the evolving landscape of biostatistics, the International Journal of Biostatistics serves as an indispensable resource through its comprehensive coverage from 2005 to 2024.
Contemporary Clinical Trials
Unveiling Insights for Safer Therapeutic InterventionsContemporary Clinical Trials, published by Elsevier Science Inc, stands at the forefront of clinical research, providing a dedicated platform for the dissemination of innovative studies and methodologies in medicine and pharmacology. With an impressive impact factor reflecting its consistent contributions to the field, this journal is categorized in the Q1 quartile for both Medicine (miscellaneous) and Pharmacology (medical) as of 2023. The journal's scope encompasses a broad range of topics pertinent to clinical trial design, execution, and analysis, aiming to enhance the effectiveness and safety of therapeutic interventions. Operating under an Open Access model, it ensures that the latest research is accessible to a global audience, fostering collaboration and discussion among researchers, professionals, and students alike. In publishing high-quality articles since its inception in 2005, Contemporary Clinical Trials continues to shape the future of clinical research with its commitment to excellence and innovation.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
Championing excellence in medical science since 1945.The American Journal of the Medical Sciences, published by Elsevier Science Inc, has been a cornerstone in the field of medicine since its inception in 1945. With ISSN 0002-9629 and E-ISSN 1538-2990, this esteemed journal provides a comprehensive forum for the dissemination of cutting-edge research and clinical advancements across various medical disciplines. It currently holds a distinguished Q2 ranking in the field of Medicine (miscellaneous) and ranks #118 out of 636 in General Medicine on Scopus, reflecting its significant impact with an 81st percentile rating. While it operates under a traditional publishing model, which ensures rigorous peer-review processes, its commitment to disseminating vital medical knowledge remains paramount. Based in the United States at STE 800, 230 Park Ave, New York, NY 10169, the journal aims to bridge the gap between research and practice, making it an invaluable resource for researchers, healthcare professionals, and students dedicated to advancing medical science and improving patient care.
Danish Medical Journal
Driving Dialogue in Contemporary Medicine.Danish Medical Journal, published by the esteemed Danish Medical Association, is a vital platform in the field of medicine, providing open access research that reflects the current advances and innovations within the medical community. With an E-ISSN of 2245-1919, this journal has established itself as a significant contributor to the discourse in general medicine, holding a commendable Q3 rank in Scopus for 2023 and placed in the 65th percentile among its peers. The journal aims to disseminate high-quality research from Denmark and beyond, fostering collaboration and dialogue across disciplines. Researchers, healthcare professionals, and students alike will find invaluable insights into contemporary medical issues and evidence-based practices within its pages. The journal, which has successfully converged its focus from 2012 to 2024, is committed to continuing its legacy of excellence and innovation in medical literature, ensuring that readers remain at the forefront of medical science.
Functional Foods in Health and Disease
Advancing Understanding of Functional Foods for Health and DiseaseFunctional Foods in Health and Disease is a respected peer-reviewed journal published by FUNCTIONAL FOOD CENTER INC, dedicated to advancing research in the fields of biochemistry, food science, medicine, and nutrition. Since its inception in 2011, this journal has provided a platform for innovative studies that connect the impact of functional foods on health and disease outcomes. With a focus on interdisciplinary research, it aims to disseminate knowledge that enhances the understanding of how specific food components can influence health and well-being. The journal is indexed with an ISSN of 2160-3855 and annually ranked in several categories, including Q4 in Biochemistry and Q3 in Food Science, Medicine, and Nutrition and Dietetics for 2023. As an open access publication, it ensures that research is widely accessible, which is crucial for fostering collaboration and discussion within the scientific community. This journal is a vital resource for researchers, practitioners, and students seeking to explore the dynamic role of functional foods in health promotion and disease prevention.
Therapeutic Innovation & Regulatory Science
Bridging the Gap Between Innovation and RegulationTherapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.
PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE
Advancing Interdisciplinary Insights in PsychotherapyPSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, published by GEORG THIEME VERLAG KG, is a distinguished peer-reviewed journal focused on the interdisciplinary fields of psychotherapy, psychosomatics, and medical psychology. Since its inception in 1980, this journal has emerged as a significant platform for researchers and professionals to disseminate findings that bridge psychological theory and clinical practice, significantly contributing to the advancement of applied psychology, clinical psychology, and psychiatry. With an ongoing convergence of research until 2024, the journal maintains a vital role in its field, holding a Q3 ranking in multiple categories as of 2023, reflecting its relevance and quality within the academic community. Though not an open-access journal, it provides crucial insights that influence both scholarly discourse and clinical methodologies, making it an essential resource for anyone engaged in understanding the complexities of mental health and psychosomatic conditions.
BMJ Open
Championing excellence in medical research and collaboration.BMJ Open is a distinguished open access journal published by the BMJ Publishing Group, dedicated to advancing the field of medicine through the dissemination of high-quality research. Since its inception in 2011, this journal has positioned itself as a pivotal platform in the medical arena, presently classified in the Q1 category of Medicine (Miscellaneous) for 2023, reflecting its commitment to excellence as evidenced by its Scopus ranking of #117 out of 636, placing it in the top 81st percentile. With its open access model, BMJ Open ensures that research is readily available to a global audience, promoting collaboration and knowledge sharing among researchers, healthcare professionals, and students alike. Located in London, UK, the journal is committed to featuring innovative research that informs clinical practice, public health, and healthcare policy, making it an essential resource for anyone engaged in medical research and practice.
Translational Behavioral Medicine
Unraveling the Complexities of Behavior and WellnessTranslational Behavioral Medicine, published by Oxford University Press, is a premier academic journal dedicated to advancing the field of behavioral medicine through high-quality research and innovative methodologies. With an ISSN of 1869-6716 and an impressive E-ISSN of 1613-9860, the journal serves as a vital platform for disseminating findings that bridge the gap between laboratory research and clinical practice. Ranking in the prestigious Q1 category for both Applied Psychology and Behavioral Neuroscience, it holds a prominent position within the academic community, as reflected by its Scopus rankings—17th out of 88 in Behavioral Neuroscience and 57th out of 249 in Applied Psychology. Although currently non-Open Access, the journal provides a wealth of knowledge for researchers, professionals, and students interested in the interplay of behavioral science and health. With converged years from 2011 to 2024, Translational Behavioral Medicine continues to be an essential resource for those committed to enhancing our understanding of how behavioral factors contribute to health and illness.